News & insights

News

Kilburn & Strode announce this year’s Partner and Counsel promotions

These promotions continue our commitment to advancing our people, investing in everyone's development, whilst looking to our future.

CRISPR

World’s first CRISPR-based therapy to be offered on the NHS in England

The role of National Institute for Heath and Care Excellence (NICE) is to provide an independent evaluation of how treatments affect health outcomes and whether they are cost-effective for the public ...

News

A cautionary tale for medical use claims in Europe

A recent, first-instance decision from an Opposition Division (OD) suggests that the European Patent Office (EPO) could tighten their assessment of medical use claims under Article 123(2) EPC (the req...

News

The EU AI Act is here: what is it, and how might it affect my IP?

In this article we set out a reminder on some key things you should know about the AI Act: which AI systems are prohibited, the disclosure and the transparency requirements that certain AI systems mus...

News

“The best firm to work with in the United Kingdom” - Kilburn & Strode sweeps the WTR 1000 2025 rankings

Kilburn & Strode again achieves the highest level of recognition from this years’ World Trademark Review, receiving three firm rankings for the UK, Benelux and EUIPO.

News

Changes to the SPC system in the UK

The UK IPO has now issued guidance on changes to the Supplementary Protection Certificates (SPCs) system in the UK which will take effect from 1 January 2025.

Covid-19

Moderna's Patent Pledge

While many think the Covid-19 is something from the past, it’s far from that in patent courts. A fierce battle on the technology behind the vaccines is going on.

News

Defining bad faith: Insights from Supreme Court’s ruling in SkyKick v Sky

The Supreme Court has handed down its highly anticipated judgement in the eight-year long litigation between Sky Ltd and SkyKick UK Ltd, centred around what constitutes a bad faith trade mark filing.

News

Nobel Prize awarded for the discovery of microRNA and its role in post-transcriptional gene regulation

Congratulations to Victor Ambros and Gary Ruvkun who were jointly awarded the 2024 Nobel Prize in Physiology or Medicine for their discovery of microRNA in the small worm C. elegans.

Let us keep you up to date. If you’d like to receive communications from us, ranging from breaking news to technical updates, thought leadership to event invitations, please let us know.

Connect with us